No insider purchase over the last 90 days. The latest, by Bagerdjian Shahe, was filed 27 May 2025.
Radnostix Inc belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). The last twelve months, up to 23 October 2026, brought 4 filings signed by 1 insider.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Over the last twelve months, not one insider purchase of Radnostix Inc stock was filed.
Across the 278 companies tracked on its exchange, the median is 8 filings; at 4 filings, this issuer sits below that mark. Over the whole record (from 2016), the tally stands at 14 purchases and no sales. In its latest annual report filed with the SEC (10-K, fiscal year ended 31 December 2025), the company reported revenue of 13.1 m USD and net income of -908,002 USD.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 86 declarations
Radnostix Inc is a company listed on the XNAS market. It specializes in the technology sector, but further information about its activities is not available.
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 13.1 m USD | -908,002 USD | 0.00 USD | 10-K |
| Dec 2024 | 13.9 m USD | 8,574 USD | 0.00 USD | 10-K |
| Dec 2023 | 12.3 m USD | -869,016 USD | 0.00 USD | 10-K |
| Dec 2022 | 11.2 m USD | 303,238 USD | 0.00 USD | 10-K |
| Dec 2021 | 9.7 m USD | -902,347 USD | 0.00 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.